false
OasisLMS
Catalog
AUGS/IUGA Scientific Meeting 2019
Long Oral Session 5 - OAB
Long Oral Session 5 - OAB
Back to course
[Please upgrade your browser to play this video content]
Video Transcription
Video Summary
The first video is a presentation on the 2019 Guideline on Recurrent Urinary Tract Infections in Women. The speaker discusses the prevalence of UTIs in women, the consequences of antibiotic overuse, and the rise of antibiotic resistance. They stress the importance of antibiotic stewardship and obtaining a complete history and pelvic exam for women with recurrent UTIs. They define acute cystitis, complicated UTI, and recurrent UTI, and discuss the associated symptoms. The speaker emphasizes the need for urinalysis, culture, and sensitivity testing before starting therapy, and advises against unnecessary surveillance urine testing. Treatment recommendations include the use of first-line antibiotics for uncomplicated UTIs, consideration of patient-initiated treatment while awaiting culture results, and prophylactic antibiotics for high-risk patients. They also mention potential benefits of vaginal estrogen and cranberry prophylaxis. The video concludes with information on the development and validation of a prediction model for response to anticholinergic treatment and a study on the effect of temperature variation on pain perception during intradural injection of Botox for overactive bladder.<br /><br />The second video summarizes a study on sacral neuromodulation for urgency incontinence using the Axonix system. The study involved 129 participants, and the primary outcome was the therapy responder rate, defined as a greater than 50% reduction in urgency incontinence episodes. At six months, 90% of participants responded to the therapy, and this response was sustained at one year with 89% still responding. The mean number of urgency incontinence episodes significantly decreased. Participants also reported improved quality of life and satisfaction rates. The charging usability of the device was found to be acceptable by 96% of participants. Device-related adverse events were minimal, leading to the conclusion that the Axonix system is a safe and effective treatment for urgency incontinence.
Asset Caption
Jennifer T. Anger, MD, MPH, David Sheyn, MD, Amos Adelowo, MD, MPH, FACOG, Barry K Jarnagin, MD, Susann Varano, Toya S. Pratt, MD, David Staskin, Felicia L. Lane, MD
Keywords
2019 Guideline on Recurrent Urinary Tract Infections
UTIs in women
antibiotic overuse
antibiotic resistance
antibiotic stewardship
complete history
pelvic exam
acute cystitis
complicated UTI
recurrent UTI
urinalysis
culture and sensitivity testing
×
Please select your language
1
English